Innovation Pharmaceuticals Inc (IPIX)

[StockJumper25]

Kevetrin - does anyone on the medical side that is following the promise of Kevetrin know, if it would help with what Lumakras is proposing as a treatment therapy??

FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy

Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy. This is the first approved targeted therapy for tumors with any KRAS mutation, which accounts for approximately 25% of mutations in non-small cell lung cancers. KRAS G12C mutations represent about 13% of mutations in non-small cell lung cancers.

GLTA Long holder’s

Just a few more weeks will tell what we are all hoping to be true.